News
HUNDREDS of thousands more Brits could be offered weight loss jabs on the NHS in the biggest shake up of diabetes care in a decade – as the health service prepares to ease rules around ...
23h
inews.co.uk on MSNNHS diabetes shake-up could save 22,000 lives with earlier access to weight-loss jabs
The NHS should move away from a one-size-fits-all approach of starting everyone on the same medication, according to new ...
Columnist Teri Sforza writes that studies have found that the popular weight-loss and diabetes drugs reduced alcohol intake, ...
Columnist Teri Sforza writes that studies have found that the popular weight-loss and diabetes drug reduced alcohol intake, ...
Columnist Teri Sforza writes that studies have found that semaglutide reduced alcohol intake, binge drinking and relapse ...
According to Google Canada, Quebec City is the first municipality in the country to partner with the web giant's Green Light ...
GLP-1 receptor agonists, including semaglutide and tirzepatide, are commonly prescribed to aid weight loss and manage type 2 diabetes. While these drugs have been effective for many patients, recent ...
You do not need to avoid alcohol while taking Ozempic. However, using them together may increase the risk of certain side ...
More than 15 million Americans are now losing weight with GLP-1 drugs. The medications — drugs like Ozempic, Wegovy and Mounjaro that were originally created to treat type 2 diabetes — have been shown ...
Novo Nordisk has reduced the price of its two semaglutide-based therapies – Ozempic for diabetes and Wegovy for obesity – to ...
Shares of Novo Nordisk ( NVO 4.81%), the Danish pharmaceuticals company famed for Ozempic and Wegovy weight loss drugs, ...
Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results